AI-Powered Drug Discovery Firm Isomorphic Labs Launches Human Trials
Alphabet’s subsidiary, Isomorphic Labs, is set to begin human trials of its AI-designed drugs, according to the company’s president Colin Murdoch. Born from DeepMind’s AlphaFold breakthrough, Isomorphic Labs combines cutting-edge AI with pharmaceutical veterans to design medicines faster, cheaper, and more accurately. Murdoch stated that researchers are already collaborating with AI in their King’s Cross … Read more